Archive for December, 2006

Medical Edge: Omega-3 acids have benefits but don't reduce cholesterol - Bryan College Station Eagle

Medical Edge: Omega-3 acids have benefits but don't reduce cholesterolBryan College Station Eagle, TX - 10 hours agoAnother option is a cholesterol-absorption inhibitor, notably, ezetimibe (Zetia is the brand), which helps reduce blood cholesterol by limiting the small …

Read full story

Comments

The Year in Review: Merck Rebuilds - Forbes

The Year in Review: Merck RebuildsForbes, NY - Dec 27, 2006The joint venture sells Schering-Plough's drugs Zetia and Vytorin, a combination of Zetia and Zocor. The company is also turning to biotech alliances and …

Read full story

Comments

The Year In Review: Merck rebuilds - BusinessWeek

The Year In Review: Merck rebuildsBusinessWeek - 3 hours agoThe joint venture sells Schering-Plough's drugs Zetia and Vytorin, a combination of Zetia and Zocor. The company is also turning to biotech alliances and …

Read full story

Comments

Health Mailbox - Wall Street Journal (subscription)

Health MailboxWall Street Journal (subscription), NY - 6 hours agoThe article noted the case of a 48-year-old man taking a combination of the cholesterol drugs Zetia and Crestor. He began drinking pomegranate juice twice a …

Read full story

Comments

Zacks Analyst Blog Highlights: Millennium Pharmaceuticals, Celgene … - Business Wire (press release)

Zacks Analyst Blog Highlights: Millennium Pharmaceuticals, Celgene …Business Wire (press release), CA - 20 minutes ago… Sales of existing drugs are tracking on plan, with earnings upside being driven by sales of the cholesterol franchise drugs Zetia and Vytorin. …

Read full story

Comments

Schering-Plough proposes governance changes - Washington Post

Schering-Plough proposes governance changesWashington Post, United States - Dec 15, 2006… Merck and Schering-Plough split ever-growing revenue from cholesterol fighters Zetia and Vytorin through a joint venture, while Schering-Plough has overseas …

Read full story

Comments

Pfizer drug loss helps rivals, sets patients back - Reuters India

Pfizer drug loss helps rivals, sets patients backReuters India, India - Dec 4, 2006Merck and Schering-Plough co-market two increasingly popular cholesterol pills, Zetia and Vytorin, expected to post collective sales this year of almost $4 …

Read full story

Comments

Schering-Plough proposes reforms - CNNMoney.com

CNNMoney.comSchering-Plough proposes reformsCNNMoney.com - 12 hours agoMerck and Schering-Plough split ever-growing revenue from cholesterol fighters Zetia and Vytorin through a joint venture, while Schering-Plough has overseas …

Read full story

Comments

Schering-Plough proposes governance changes - MSN Money

Schering-Plough proposes governance changesMSN Money - 2 hours agoMerck and Schering-Plough split ever-growing revenue from cholesterol fighters Zetia and Vytorin through a joint venture, while Schering-Plough has overseas …

Read full story

Comments

Ahead of the Bell: Merck,Schering-Plough - Forbes

Ahead of the Bell: Merck,Schering-PloughForbes, NY - Dec 4, 2006Merck and Schering-Plough make Zetia and Vytorin, a combination of Zetia and Merck's Zocor. Global sales of the drugs passed the $1 billion mark for the …

Read full story

Comments

· « Previous entries